Mo1476 REGIONAL DIFFERENCE IN HEPATOCELLULAR CARCINOMA INCIDENCE TRENDS: A TWO-DECADE NATIONWIDE US ANALYSIS
Leggi →
Maggio 2024
Risultati per: Terapia sistemica del carcinoma epatocellulare
Questo è quello che abbiamo trovato per te
687 PERFORMANCE AND NUTRITIONAL STATUS ARE EACH INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA RECEIVING IMMUNOTHERAPY
Leggi →
Maggio 2024
Mo1503 GLOBAL PREVALENCE, CLINICAL CHARACTERISTICS, SURVEILLANCE, TREATMENT ALLOCATION, AND OUTCOMES OF ALCOHOL-ASSOCIATED HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND METAANALYSIS
Leggi →
Maggio 2024
Sa1648 CHECKING IS LACKING: SUBOPTIMAL SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH SUSTAINED VIROLOGIC RESPONSE AFTER DIRECT-ACTING ANTIVIRAL THERAPY FOR HEPATITIS C
Leggi →
Maggio 2024
Su1540 THE IMPACT OF GLP AGONISTS ON CIRRHOSIS, HEPATOCELLULAR CARCINOMA, AND MORTALITY IN PATIENTS WITH MASH: A FIVE-YEAR ANALYSIS
Leggi →
Maggio 2024
Su1527 HIGHER INCIDENCE OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN LEAN VS. OVERWEIGHT/OBESE VETERANS WITH MASLD
Leggi →
Maggio 2024
Tu1572 RACIAL DISPARITIES IN HEPATOCELLULAR CARCINOMA BASED ON TUMOR STAGE AT DIAGNOSIS: A NATIONWIDE POPULATION-BASED ANALYSIS USING THE UNITED STATES CANCER STATISTICS (USCS) DATABASE, 2001-2020
Leggi →
Maggio 2024
Tu1581 DIDS INHIBITS THE CARCINOGENESIS AND GROWTH OF HEPATOCELLULAR CARCINOMA IN MICE
Leggi →
Maggio 2024
Tu1580 HIGH CHLORIDE INTAKE INHIBITS THE CARCINOGENESIS AND GROWTH OF HEPATOCELLULAR CARCINOMA IN MICE
Leggi →
Maggio 2024
Tu1577 MORTALITY IN PATIENTS TREATED WITH TRANSARTERIAL RADIOEMBOLIZATION (TARE) OR SBRT FOR HEPATOCELLULAR CARCINOMA (HCC)
Leggi →
Maggio 2024
Tu1137 ESOPHAGEAL AND GASTRIC CARDIA PRECURSOR LESIONS AND RISK OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND GASTRIC CARDIA ADENOCARCINOMA IN POPULATION-BASED, PROSPECTIVE COHORTS IN CHINA
Leggi →
Maggio 2024
Tu1569 PREVALENCE OF SARCOPENIA AND ITS RELATED FACTORS AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
Leggi →
Maggio 2024
Tu1568 COMPARATIVE ANALYSIS OF THE SAFETY OF NON-TRANSPLANT TREATMENT OPTIONS FOR EARLY- TO INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA ACROSS A LARGE, INTEGRATED HEALTH CARE SYSTEM IN NORTHERN CALIFORNIA.
Leggi →
Maggio 2024
Tu1565 ENHANCEMENT PATTERN MAPPING FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS
Leggi →
Maggio 2024
Tu1564 SINGLE-CENTER STUDY ON SEX DISPARITIES IN RISK FACTORS FOR HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1584 INTRATUMORAL IMMUNE MODULATION FOR HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
